Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005; 7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14a-0501. Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005; 7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14b-0501. Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005; 7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14c-0501. Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions, Option Assessment Karine Morin, LLM Virtual Mentor. 2005; 7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15a-0501. Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions Option Comparison Karine Morin, LLM Virtual Mentor. 2005; 7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15b-0501. Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions, Additional Information Karine Morin, LLM Virtual Mentor. 2005; 7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15c-0501. Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 1 Courtenay R. Bruce, JD and Anne Lederman Flamm, JD Physicians must ask themselves ethical questions before recommending participation in phase I trials to patients. Virtual Mentor. 2009; 11(3):207-211. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903. Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 2 Thomas W. LeBlanc, MD, MA and Philip M. Rosoff, MD, MA Physicians must ask themselves ethical questions before recommending participation in phase I trials to patients. Virtual Mentor. 2009; 11(3):211-214. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903. Policy Forum Sep 2009 Direct-to-Consumer Personal Genome Services: Need for More Oversight Emily E. Anderson, PhD, MPH There is a market for direct-to-consumer genetic testing and a need for better consumer information and more regulation of tests and testing laboratories. Virtual Mentor. 2009; 11(9):701-708. doi: 10.1001/virtualmentor.2009.11.9.pfor1-0909. Medical Education Sep 2009 What Is the Role of Nongeneticist Physicians, and Are They Prepared for It? Kelly E. Ormond, MS, CGC Physicians have knowledge and skill gaps in their ability to manage the care of families with gene-related illness. Virtual Mentor. 2009; 11(9):678-682. doi: 10.1001/virtualmentor.2009.11.9.medu1-0909. Pagination First page « First Previous page ‹ Previous … Page 14 Page 15 Page 16 Page 17 Current page 18 Page 19 Page 20 Page 21 Page 22 … Next page Next › Last page Last »
Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Option Assessment Jennifer Reenan, MD Virtual Mentor. 2005; 7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14a-0501.
Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Option Comparison Jennifer Reenan, MD Virtual Mentor. 2005; 7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14b-0501.
Case and Commentary Jan 2005 Mrs. Scott's Plan for the Future, Additional Information Jennifer Reenan, MD Virtual Mentor. 2005; 7(1):80-86. doi: 10.1001/virtualmentor.2005.7.1.ccas14c-0501.
Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions, Option Assessment Karine Morin, LLM Virtual Mentor. 2005; 7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15a-0501.
Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions Option Comparison Karine Morin, LLM Virtual Mentor. 2005; 7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15b-0501.
Case and Commentary Jan 2005 Respecting Patients' End-of-Life Decisions, Additional Information Karine Morin, LLM Virtual Mentor. 2005; 7(1):87-95. doi: 10.1001/virtualmentor.2005.7.1.ccas15c-0501.
Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 1 Courtenay R. Bruce, JD and Anne Lederman Flamm, JD Physicians must ask themselves ethical questions before recommending participation in phase I trials to patients. Virtual Mentor. 2009; 11(3):207-211. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903.
Case and Commentary Mar 2009 Is There a Duty to Inform Patients of Phase I Trials? Commentary 2 Thomas W. LeBlanc, MD, MA and Philip M. Rosoff, MD, MA Physicians must ask themselves ethical questions before recommending participation in phase I trials to patients. Virtual Mentor. 2009; 11(3):211-214. doi: 10.1001/virtualmentor.2009.11.3.ccas2-0903.
Policy Forum Sep 2009 Direct-to-Consumer Personal Genome Services: Need for More Oversight Emily E. Anderson, PhD, MPH There is a market for direct-to-consumer genetic testing and a need for better consumer information and more regulation of tests and testing laboratories. Virtual Mentor. 2009; 11(9):701-708. doi: 10.1001/virtualmentor.2009.11.9.pfor1-0909.
Medical Education Sep 2009 What Is the Role of Nongeneticist Physicians, and Are They Prepared for It? Kelly E. Ormond, MS, CGC Physicians have knowledge and skill gaps in their ability to manage the care of families with gene-related illness. Virtual Mentor. 2009; 11(9):678-682. doi: 10.1001/virtualmentor.2009.11.9.medu1-0909.